Literature DB >> 33224506

Mass culling of minks to protect the COVID-19 vaccines: is it rational?

R Frutos1,2, C A Devaux3.   

Abstract

The Danish Government announced the culling of 17 million minks in rearing after the report of mink-specific mutations of severe acute respiratory syndrome coronavirus 2 in humans. The rationale behind this decision is that these mutations might negatively impact the deployment of anti-coronavirus disease 2019 vaccines. Is it a precautionary attitude or a panic-driven overreaction?
© 2020 The Author(s).

Entities:  

Keywords:  Coronavirus disease 2019; culling; mink; severe acute respiratory syndrome coronavirus 2

Year:  2020        PMID: 33224506      PMCID: PMC7670899          DOI: 10.1016/j.nmni.2020.100816

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


To the Editor, The Danish Government released on Wednesday 4 November 2020 a statement, relayed by WHO on 6 November 2020 [1], that the 17 million minks present within all mass-rearing facilities in Denmark would be culled. This decision was based on the identification in September 2020 of a novel variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 12 people in North Jutland, Denmark. This variant was also found in a mink-rearing facility. The 12 individuals were linked to the mink rearing. This variant was considered as bearing mink-related mutations. Fearing that these mutations may be a threat to the human population and that they might interfere with future anti-SARS-CoV-2 vaccines, the decision was taken to cull all of the 17 million minks in Denmark. These mutations have not been made public and there is no evidence yet that the mutations observed in the minks in Denmark will affect the development of vaccines in humans. A rational attitude would be to isolate those minks while more information is gathered on the true meaning of the mutations observed. SARS-CoV-2, like other coronaviruses and RNA viruses, is evolving through a quasispecies mechanism [[2], [3], [4]]. A main characteristic of the quasispecies evolutionary process is the generation of post-infection mutations under positive selective pressure, i.e. host-driven viral evolution [5]. Therefore, mutations are not pre-existing but instead are acquired after infection and are specific to the host, usually allowing the virus to escape host defence mechanisms [6,7]. SARS-CoV-2 can infect both humans and minks, each one being a source of infection [8]. SARS-CoV-2 variants reported in minks in Denmark [1] are very likely to be ‘mink signatures’, i.e. adaptation to the host. In turn, humans infected with a virus coming from minks are most likely to force the virus to mutate to evade the human immune defence system. Mutations in humans will therefore be different from those in minks. Mink is not the only species outside humans to be infected by SARS-CoV-2. Many other wild animals such as bats, pangolins, palm civets, ferrets, monkeys, turtles, snakes and even whales can potentially be infected because they bear a compatible angiotensin-converting enzyme 2 receptor [9]. However, this is not limited to wild animals and several domestic species display the same trait, including cats, dogs, pigs, sheep, cows, water buffalo, goats and pigeons [9]. These wild and domestic animals present the same risk of infecting humans back with SARS-CoV-2. Coronavirus disease 2019 has been clearly shown in cats and dogs, which are humans' closest companions [10]. Should we take the same decision as with minks and cull them? This would be irrational behaviour. Minks might show specific mutations because of the mass-rearing conditions and containment, which generate a high population density, a high rate of contacts and fast frequency increase of viral genotypes that have evolved in the host. The spillover model of pre-existing adapted ‘human-active’ genotypes in the wild has never been demonstrated and another model, the circulation model, has been proposed to explain the in-host evolution of ‘human-active’ mutations after transmission and circulation of the virus in humans [9]. Fear is commonly observed in the face of a pandemic. However, fear and panic should not be the drivers because they lead to irrational reactions. Culling millions of animals with no evidence of actual danger but simply on the basis of fear is setting up a dangerous precedent. The risk is high then to consider that the safest way of protecting humans from any zoonosis would be to eradicate the animals around. Humans are exposed to diseases. It is a natural process that we cannot deny and we cannot avoid. The right attitude is not to cull and eradicate all putative threats as a precaution but instead, as we occupy all the planet with a very large and still growing population, to ask ourselves how human activities impact the emergence and diffusion of infectious diseases. Human activities are the real drivers of epidemics and pandemics. The rational behaviour would then be to organize these activities properly to reduce that risk instead of building a safety dome by eradicating all supposed sources of infection.

Ethics declarations

No human samples or clinical data were used.

Author contributions

RF and CAD contributed equally to the manuscript. Both authors participated in the writing and correction of the manuscript. Both authors read and agreed with the manuscript.

Funding

The only funding sources involved are the institutions of affiliation of each author: CIRAD for RF and CNRS and IHU Mediterranee-Infection for CAD. The involvement of the funding sources was limited to the salaries of the authors, with no other role or involvement.

Conflicts of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  7 in total

1.  SARS-associated coronavirus quasispecies in individual patients.

Authors:  Dongping Xu; Zheng Zhang; Fu-Sheng Wang
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

2.  A quantitative quasispecies theory-based model of virus escape mutation under immune selection.

Authors:  Hyung-June Woo; Jaques Reifman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

3.  Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort.

Authors:  Leon Cali; Bin Wang; Meriet Mikhail; Michael J Gill; Brenda Beckthold; Marco Salemi; David A Jans; Sabine C Piller; Nitin K Saksena
Journal:  AIDS Res Hum Retroviruses       Date:  2005-08       Impact factor: 2.205

4.  The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic.

Authors:  Eric M Leroy; Meriadeg Ar Gouilh; Jeanne Brugère-Picoux
Journal:  One Health       Date:  2020-04-13

5.  Evolution of viral quasispecies during SARS-CoV-2 infection.

Authors:  Aude Jary; Valentin Leducq; Isabelle Malet; Stéphane Marot; Elise Klement-Frutos; Elisa Teyssou; Cathia Soulié; Basma Abdi; Marc Wirden; Valérie Pourcher; Eric Caumes; Vincent Calvez; Sonia Burrel; Anne-Geneviève Marcelin; David Boutolleau
Journal:  Clin Microbiol Infect       Date:  2020-07-24       Impact factor: 13.310

6.  SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.

Authors:  Timokratis Karamitros; Gethsimani Papadopoulou; Maria Bousali; Anastasios Mexias; Sotirios Tsiodras; Andreas Mentis
Journal:  J Clin Virol       Date:  2020-08-11       Impact factor: 3.168

7.  COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans.

Authors:  Roger Frutos; Jordi Serra-Cobo; Tianmu Chen; Christian A Devaux
Journal:  Infect Genet Evol       Date:  2020-08-05       Impact factor: 3.342

  7 in total
  10 in total

Review 1.  Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Authors:  Bassel Akache; Felicity C Stark; Gerard Agbayani; Tyler M Renner; Michael J McCluskie
Journal:  Methods Mol Biol       Date:  2022

2.  Zoonotic and anthropozoonotic potential of COVID-19 and its implications for public health.

Authors:  Amr El-Sayed; Mohamed Kamel; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-14       Impact factor: 5.190

Review 3.  COVID-19 in Farm Animals: Host Susceptibility and Prevention Strategies.

Authors:  Sachin Subedi; Sulove Koirala; Lilong Chai
Journal:  Animals (Basel)       Date:  2021-02-28       Impact factor: 2.752

4.  Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?

Authors:  Christian A Devaux; Lucile Pinault; Ikram Omar Osman; Didier Raoult
Journal:  Front Public Health       Date:  2021-02-10

Review 5.  Mink, SARS-CoV-2, and the Human-Animal Interface.

Authors:  Florence Fenollar; Oleg Mediannikov; Max Maurin; Christian Devaux; Philippe Colson; Anthony Levasseur; Pierre-Edouard Fournier; Didier Raoult
Journal:  Front Microbiol       Date:  2021-04-01       Impact factor: 5.640

Review 6.  Update on Potentially Zoonotic Viruses of European Bats.

Authors:  Claudia Kohl; Andreas Nitsche; Andreas Kurth
Journal:  Vaccines (Basel)       Date:  2021-06-23

7.  There is no "origin" to SARS-CoV-2.

Authors:  Roger Frutos; Olivier Pliez; Laurent Gavotte; Christian A Devaux
Journal:  Environ Res       Date:  2021-10-06       Impact factor: 6.498

8.  The ecology of the banded civet (Hemigalus derbyanus) in Southeast Asia with implications for mesopredator release, zoonotic diseases, and conservation.

Authors:  Ashlea Dunn; Zachary Amir; Henri Decoeur; Bastien Dehaudt; Ilyas Nursamsi; Calebe Mendes; Jonathan H Moore; Pablo Jose Negret; Adia Sovie; Matthew Scott Luskin
Journal:  Ecol Evol       Date:  2022-04-28       Impact factor: 3.167

9.  Alternative Paradigms in Animal Health Decisions: A Framework for Treating Animals Not Only as Commodities.

Authors:  Noguera Z Liz Paola; Paul R Torgerson; Sonja Hartnack
Journal:  Animals (Basel)       Date:  2022-07-20       Impact factor: 3.231

10.  SARS-ANI: a global open access dataset of reported SARS-CoV-2 events in animals.

Authors:  Afra Nerpel; Liuhuaying Yang; Johannes Sorger; Annemarie Käsbohrer; Chris Walzer; Amélie Desvars-Larrive
Journal:  Sci Data       Date:  2022-07-23       Impact factor: 8.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.